<DOC>
	<DOCNO>NCT00331565</DOCNO>
	<brief_summary>Altered bioavailability drug potentially affect drug efficacy well safety . In patient subject bariatric surgery due morbid obesity gastro intestinal tract considerably reconstruct change drug bioavailability likely . Getting knowledge important mechanism responsible altered bioavailability would help predict clinically relevant consequence different drug . In present study aim investigate effect bariatric surgery atorvastatin bioavailability . Atorvastatin subject extensive metabolism drug transport potentially good predictor mechanism relevant drug well . In addition expression different enzymes transporter measure gastrointestinal tract liver elucidate mechanism behind eventual effect .</brief_summary>
	<brief_title>Investigations Influence Bariatric Surgery Metabolism Absorption Atorvastatin</brief_title>
	<detailed_description>The primary objective study compare effect gastric bypass BPD+DS operation atorvastatin bioavailability . Secondary objective determine relative change atorvastatin bioavailability follow gastric bypass well BPD+DS operation . In addition individual CYP3A4 , CYP3A5 P-gp activity different organ biopsy obtain descriptively compare atorvastatin pharmacokinetic variable .</detailed_description>
	<mesh_term>Obesity , Morbid</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Scheduled bariatric surgery . 18 year age old . Ongoing treatment statin . Able willing donate GItract liver biopsy . Signed informed consent . Concomitant treatment drug and/or factor may influence atorvastatin pharmacokinetics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Bariatric surgery</keyword>
	<keyword>Bioavailability</keyword>
	<keyword>Bioequivalence</keyword>
	<keyword>Atorvastatin</keyword>
	<keyword>CYP 's</keyword>
	<keyword>P-gp</keyword>
	<keyword>OATP</keyword>
</DOC>